Eileen Dimond

1.2k total citations
38 papers, 861 citations indexed

About

Eileen Dimond is a scholar working on Genetics, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Eileen Dimond has authored 38 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 12 papers in Public Health, Environmental and Occupational Health and 11 papers in Oncology. Recurrent topics in Eileen Dimond's work include BRCA gene mutations in cancer (10 papers), Ethics in Clinical Research (8 papers) and Genetic factors in colorectal cancer (6 papers). Eileen Dimond is often cited by papers focused on BRCA gene mutations in cancer (10 papers), Ethics in Clinical Research (8 papers) and Genetic factors in colorectal cancer (6 papers). Eileen Dimond collaborates with scholars based in United States, Malaysia and Italy. Eileen Dimond's co-authors include Jean Jenkins, Ilan R. Kirsch, Donald W. Hadley, Seth M. Steinberg, Kenneth Nakahara, Liam Grogan, David J. Liewehr, Christina G.S. Palmer, Peter W. Soballe and Andrea Denicoff and has published in prestigious journals such as Journal of Clinical Oncology, PEDIATRICS and Cancer.

In The Last Decade

Eileen Dimond

37 papers receiving 834 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eileen Dimond United States 14 342 226 215 205 190 38 861
Laura Fejerman United States 21 524 1.5× 440 1.9× 92 0.4× 215 1.0× 88 0.5× 60 1.1k
Ron Zimmern United Kingdom 17 1.1k 3.3× 211 0.9× 191 0.9× 435 2.1× 273 1.4× 35 1.6k
Veda N. Giri United States 20 422 1.2× 368 1.6× 192 0.9× 256 1.2× 123 0.6× 79 1.2k
Joan Murphy Canada 21 675 2.0× 532 2.4× 320 1.5× 177 0.9× 274 1.4× 43 2.1k
Flavia M. Facio United States 13 650 1.9× 48 0.2× 94 0.4× 149 0.7× 285 1.5× 25 1.0k
Maureen Joffe South Africa 18 127 0.4× 721 3.2× 141 0.7× 149 0.7× 143 0.8× 76 1.1k
Katherine A. Schneider United States 22 817 2.4× 308 1.4× 238 1.1× 329 1.6× 168 0.9× 58 1.6k
P. Engstrom United States 6 220 0.6× 336 1.5× 40 0.2× 139 0.7× 64 0.3× 9 714
Ranjit Manchanda United Kingdom 25 1.2k 3.6× 477 2.1× 239 1.1× 321 1.6× 263 1.4× 142 2.2k
Charité Ricker United States 17 871 2.5× 258 1.1× 213 1.0× 297 1.4× 190 1.0× 60 1.1k

Countries citing papers authored by Eileen Dimond

Since Specialization
Citations

This map shows the geographic impact of Eileen Dimond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen Dimond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen Dimond more than expected).

Fields of papers citing papers by Eileen Dimond

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eileen Dimond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen Dimond. The network helps show where Eileen Dimond may publish in the future.

Co-authorship network of co-authors of Eileen Dimond

This figure shows the co-authorship network connecting the top 25 collaborators of Eileen Dimond. A scholar is included among the top collaborators of Eileen Dimond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eileen Dimond. Eileen Dimond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Oukseub, Latifa A. Bazzi, Yanfei Xu, et al.. (2024). A randomized Phase I pre-operative window trial of transdermal endoxifen in women planning mastectomy: Evaluation of dermal safety, intra-mammary drug distribution, and biologic effects. Biomedicine & Pharmacotherapy. 171. 116105–116105. 2 indexed citations
2.
Zeng, Yi, Anna‐Barbara Moscicki, Chiu‐Hsieh Hsu, et al.. (2023). HPV16/18 Antibody Responses After a Single Dose of Nonavalent HPV Vaccine. PEDIATRICS. 152(1). 7 indexed citations
3.
Clifton, Guy T., Brandy M. Heckman‐Stoddard, Eileen Dimond, et al.. (2023). Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ. Cancer Prevention Research. 16(6). 333–341. 12 indexed citations
4.
Trivedi, Meghna S., Nadir Arber, Eitan Friedman, et al.. (2022). Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy. Cancer Prevention Research. 15(11). 721–726. 3 indexed citations
5.
Patel, Anisha B., J. Jack Lee, Diane D. Liu, et al.. (2022). Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast Cancer. Cancer Prevention Research. 16(1). 47–55. 4 indexed citations
6.
Adhikari, Bishow B., et al.. (2022). Spectrum of National Institutes of Health-Funded Research in Cardio-Oncology. Heart Failure Clinics. 18(3). 515–528. 5 indexed citations
7.
Clifton, Guy T., Na Qiao, Brandy M. Heckman‐Stoddard, et al.. (2021). Abstract PD11-09: Vadis trial: Phase II trial of nelipepimut-s peptide vaccine in women with DCIS of the breast. Cancer Research. 81(4_Supplement). PD11–9. 1 indexed citations
8.
Shelburne, Nonniekaye, Naoko I. Simonds, Bishow B. Adhikari, et al.. (2019). Changing Hearts and Minds: Improving Outcomes in Cancer Treatment-Related Cardiotoxicity. Current Oncology Reports. 21(1). 9–9. 15 indexed citations
9.
Minasian, Lori M., Eileen Dimond, Bishow B. Adhikari, et al.. (2019). The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity. JACC CardioOncology. 1(1). 105–113. 14 indexed citations
10.
11.
Upshaw, Jenica, Anne O’Neill, Joseph R. Carver, et al.. (2018). Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal. Clinical Colorectal Cancer. 18(1). 44–51. 22 indexed citations
12.
Dimond, Eileen, Diane St. Germain, Howard A. Zaren, et al.. (2015). Creating a “culture of research” in a community hospital: Strategies and tools from the National Cancer Institute Community Cancer Centers Program. Clinical Trials. 12(3). 246–256. 38 indexed citations
13.
Jenkins, Jean, Eileen Dimond, David J. Liewehr, et al.. (2007). Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling. Genetics in Medicine. 9(8). 487–495. 56 indexed citations
14.
Hadley, Donald W., Jean Jenkins, Eileen Dimond, et al.. (2003). Genetic Counseling and Testing in Families With Hereditary Nonpolyposis Colorectal Cancer. PubMed. 163(5). 573–573. 124 indexed citations
15.
Jenkins, Jean, Eileen Dimond, & Seth M. Steinberg. (2001). Preparing for the Future Through Genetics Nursing Education. Journal of Nursing Scholarship. 33(2). 191–195. 29 indexed citations
16.
Jenkins, Jean, Cynthia A. Prows, Eileen Dimond, Rita Black Monsen, & Janet K. Williams. (2001). Recommendations for educating nurses in genetics. Journal of Professional Nursing. 17(6). 283–290. 43 indexed citations
17.
Dimond, Eileen, et al.. (1998). The Role of the Nurse in Cancer Genetics. Cancer Nursing. 21(1). 57–75. 17 indexed citations
18.
Dimond, Eileen, et al.. (1997). Programmed Instruction: Human Genetics. Cancer Nursing. 20(3). 213–226. 8 indexed citations
19.
Peters, June A., Eileen Dimond, & Jean Jenkins. (1997). Clinical Applications of Genetic Technologies to Cancer Care. Cancer Nursing. 20(5). 359–377. 4 indexed citations
20.
Dimond, Eileen, et al.. (1993). A cancer day hospital: an alternative approach to caring for patients in clinical trials.. PubMed. 20(5). 787–93. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Fejerman Breakdown of academic impact, for papers by Ron Zimmern Breakdown of academic impact, for papers by Veda N. Giri Breakdown of academic impact, for papers by Joan Murphy Breakdown of academic impact, for papers by Flavia M. Facio Breakdown of academic impact, for papers by Maureen Joffe Breakdown of academic impact, for papers by Katherine A. Schneider Breakdown of academic impact, for papers by P. Engstrom Breakdown of academic impact, for papers by Ranjit Manchanda Breakdown of academic impact, for papers by Charité Ricker
Rankless by CCL
2026